Novel cannabinol probes for CB1 and CB2 cannabinoid receptors

Journal of Medicinal Chemistry

Volumn 43, Issue 20, 2000, Pages 3778-3785

  Mahadevan, A ^a   Siegel, C ^a   Martin, B R ^b   Abood, M E ^b   Beletskaya, I ^b   Razdan, R K ^a  

^a ORGANIX INC   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHOXY 3 (1',1' DIMETHYLHEPTYL) 11 OICESTER CANNABINOL; 11 HYDROXYCANNABINOL DERIVATIVE; 9 CARBOMETHOXYCANNABINOL DERIVATIVE; CANNABINOID RECEPTOR; CANNABINOL DERIVATIVE; LITHIUM DERIVATIVE; PHOSPHATE; RECEPTOR SUBTYPE; SELENIUM DERIVATIVE; SODIUM CHLORITE; SULFUR; TETRAHYDROCANNABINOL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; HYDROGENATION; OXIDATION; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION;

ANIMALS; BRAIN; CANNABINOIDS; CANNABINOL; LIGANDS; RADIOLIGAND ASSAY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034609803     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0001572     Document Type: Article

References (33)

1. Phamacological, physiological and clinical implications of the discovery of cannabinoid receptors: An overview
2. Pharmacology of cannabinoid CB1 and CB2 receptors
3. Recent developments in the medicinal chemistry of cannabinoids
4. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
5. Molecular characterization of a peripheral receptor for cannabinoids
6. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
7. 2-Arachidonoyl-glycerol: A possible endogenous cannabinoid receptor ligand in brain
8. Discovery and characterization of endogenous cannabinoids
9. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
10. SR144528, an antagonist for the peripheral cannabinoid receptor that behaves as an inverse agonist
11. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
12. Second endogenous cannabinoid that modulates long-term potentiation
13. Functional role of high-affinity anandamide transport, as revealed by selective inhibition
14. Structure activity relationships in cannabinoids
15. Structure activity relationships for cannabinoid receptor-binding and analgesic activity: Studies of bicyclic cannabinoid analogues
16. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation
17. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands
18. Cannabinol derivatives: Binding to cannabinoid receptors and inhibition of adenylylcyclase
19. Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors
20. Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor
21. 8-THC and related compounds: Synthesis of selective ligands for the CB2 receptor
22. Structure of cannabidiol. VI. Isomerisation of cannabidiol to tetrahydrocannabinol, a physiologically active product. Conversion of cannabidiol to cannabinol
23. Synthesis of 5-(tert-Alkyl) resorcinols
24. 9-tetrahydrocannabinol (THC) metabolites
25. A method of reducing phenols to aromatic hydrocarbons
26. 1((6))-THC metabolites
27. 6- THC with selenium dioxide
28. 9-Tetrahydrocannabinol (THC) and related compounds: An improved oxidative procedure
29. Pharmacological profile of a series of bicyclic cannabinoid analogues: Classification as cannabimimetic agents
30. 50) on an enzymatic reaction